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Abstract
Backbone N-methylation is common among peptide natural products and has a significant impact 
on both the physical properties and the conformational states of cyclic peptides. However, the 
specific impact of N-methylation on passive membrane diffusion in cyclic peptides has not been 
investigated systematically. Here we report a method for the selective, on-resin N-methylation of 
cyclic peptides to generate compounds with drug-like membrane permeability and oral 
bioavailability. The selectivity and degree of N-methylation of the cyclic peptide was determined 
by backbone stereochemistry, suggesting that conformation dictates the regiochemistry of the N-
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methylation reaction. The permeabilities of the N-methyl variants were corroborated by 
computational studies on a 1024-member virtual library of N-methyl cyclic peptides. One of the 
most permeable compounds, a cyclic hexapeptide (MW = 755) with three N-methyl groups, 
showed an oral bioavailability of 28% in rat.
Introduction
Macrocyclic compounds have gained increasing attention as an untapped structural class in 
drug lead discovery programs1,2. Because of their size and relative complexity, macrocycles 
can show greater specificity and potency for biological targets compared to smaller acyclic 
compounds3 and may provide useful scaffolds for modulating more challenging biological 
targets such as protein-protein interactions or biomolecules that lack well-defined small 
molecule binding sites. Although there are over 100 macrocyclic drugs in clinical use today 
(e.g., cyclosporine A (CSA), romidepsin, rapamycin, vancomycin, and rifampacin), 
macrocycles as a class are underrepresented in commercial screening libraries. Many of 
these drugs are based on natural and synthetic cyclic peptide scaffolds1, which are generally 
larger and more complex than traditional synthetic small molecule drugs. Cyclic peptides 
tend to have molecular weights and polar group counts that place them outside most 
classical definitions of “drug-likeness”, challenging us to devise new rules for predicting 
pharmacokinetic properties (e.g., oral absorption) for this class of compounds.
Backbone N-methylation is a hallmark of cyclic peptide natural products, and seems to be 
correlated with increased membrane permeability in this class of compounds. Indeed, N-
methylation has been shown to improve oral bioavailability while maintaining or even 
enhancing the bioactivity and selectivity of the modified scaffold4–6. In a recent study of a 
series of cyclic hexapeptides, Ovadia et al.7 demonstrate that both the number of N-methyl 
groups and, more importantly, their relative positions along the backbone, can have a 
dramatic effect on cell permeability, although they did not explicitly investigate the role of 
conformation in determining permeability.
The effect of N-methylation on the biological activity of cyclic peptides has also been 
examined, notably in the cases of somatostatin4, Arg-Gly-Asp (RGD)8, and the 
melanocortin5 family of peptides. The observation that most bioactive cyclic peptide natural 
products are N-methylated suggests that N-methylation may facilitate membrane 
permeability in these compounds; however, the relationship between N-methylation, 
conformation, and passive membrane diffusion in cyclic peptides has not been investigated 
systematically.
Crystal structures of N-methylated cyclic peptides (CSA9, ABA10, and the destruxins11) 
suggest that N-methylation may serve to increase membrane permeability by allowing (or 
possibly stabilizing) intramolecular hydrogen bonding in the membrane-associated state 
(Figure 1a). This hypothesis is consistent with previous reports studying the effect of 
conformation on membrane permeability in cyclic peptides12–16 and non-peptides17 in 
which intramolecular hydrogen bonding is a key determinant of passive membrane diffusion 
in flexible molecules containing hydrogen bond donors and acceptors. Based on this 
conformational hypothesis, we investigated whether intramolecular hydrogen bonding could 
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be used to direct the N-methylation of a cyclic peptide scaffold on the solid phase (Figure 
1b), and whether selective N-methylation could be used to improve the passive membrane 
permeability of the parent scaffolds. We reasoned that the same conformational 
determinants that influence permeability in non-methylated cyclic peptides could be 
employed to impart selectivity by directing N-methylation to the most exposed N-H groups. 
Moreover, we postulated that the resulting N-methyl derivatives would exhibit improved 
membrane permeability relative to the non-methylated parent compounds.
Here we report the use of cyclic hexapeptide scaffolds to investigate the interplay between 
N-methylation, conformation, and permeability, and we report a novel synthetic method for 
obtaining cyclic peptides with pharmacokinetic properties that rival those of typical small 
molecule drugs. We found that certain partially N-methylated cyclic peptides were more 
permeable than the corresponding fully N-methylated species, and that, consistent with 
detailed computational predictions, the permeabilities of cyclic peptides with the same 
number of N-methyl groups varied widely. In general, the relative permeabilities predicted 
by our model are borne out in in vitro and in vivo pharmacokinetics studies.
Results
We selected the cyclic hexapeptide sequence cyclo[Leu, Leu, Leu, Leu, Pro, Tyr] as a test 
scaffold to screen for conditions that might afford regioselective N-methylation on the solid 
phase. A single Pro residue is known to promote efficient cyclization, even in all-L 
hexapeptides18, and similar cyclic hexapeptides are known to adopt different conformations 
depending on the arrangement of D- and L-residues in the sequence12. We synthesized the 
linear peptides by linking the Tyr side chain to the resin with C-terminal protection as the 
allyl ester, followed by deprotection and cyclization on the solid phase13. After testing a 
variety of diastereomers under a range of N-methylation conditions, we identified a 
sequence, cyclo[Leu, D-Leu, Leu, Leu, D-Pro, Tyr] (1), that gave excellent selectivity in the 
on-resin N-methylation reaction. Thus, when we treated the resin-bound cyclic peptide with 
excess LiOtBu in THF, followed by excess CH3I in DMSO, we observed nearly complete 
conversion to a single trimethylated species (Table S4 entry 9). These conditions had been 
reported previously for the on-resin peralkylation of linear peptides19, 20, suggesting that the 
selectivity we observed was due to the cyclic nature of the starting peptide. A more detailed 
evaluation of reaction conditions for 1 is described in the Supplemental Information.
N-methylation regiochemistry
Since α-carbon stereochemistry can have a significant impact on conformation in cyclic 
peptides21, we examined the effect of stereochemistry on the selectivity of N-methylation by 
performing the methylation reaction on 32 stereoisomers based on the sequence cyclo[D/
LLeu-D/LLeu-D/LLeu-D/LLeu-D/LPro-LTyr] (Figure 2). Among the 29 diastereomers that 
cyclized efficiently on the solid phase, 6 sequences yielded specific N-methyl adducts with 
>95% selectivity when treated with the same on-resin N-methylation conditions described 
above for 1 (Figure 2, arrows). Three of these sequences yielded a trimethyl product 
(scaffolds 3, 19, and 27), and three yielded a tetramethyl product (scaffolds 2, 18, and 26). 
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The remaining sequences yielded permethylated product (2 sequences), returned starting 
material (4 sequences), or gave mixtures of varying complexity (17 sequences).
A pattern emerged in the relationship between stereochemistry and selectivity among the 6 
highly selective scaffolds. The three trimethylated scaffolds were identical in four 
contiguous residues (Tyr6-Leu1-Leu2-Leu3) with the consensus sequence cyclo[LLeu-DLeu-
LLeu-D/LLeu-D/LPro-LTyr] (Figure 2b). The three tetramethylated scaffolds were identical 
at the same four contiguous residues, but shared a different consensus sequence: 
cyclo[DLeu-LLeu-LLeu-D/LLeu-D/LPro-LTyr]. We chose two of the selective, partially N-
methylated products for further study: the trimethyl variant of scaffold 19 (3) and the 
tetramethyl variant of scaffold 18 (4).
Using 2D NMR techniques (HMBC, HMQC, TOCSY, COSY and NOESY), we determined 
the pattern of N-methylation for 1 and 2 (Figure 3a). Compound 1 yielded exclusively the 
trimethyl adduct shown in Figure 3a (3), in which residues D-Leu2, Leu3 and Tyr6 were N-
methylated. Diastereomer 2 yielded a single tetramethyl adduct (4), in which residues D-
Leu1, Leu2, Leu4, and Tyr6 were N-methylated, (Figure 3a). Thus, the transposition of only 
two stereocenters between 1 and 2 (Leu1 and Leu2) led to a complete shift in both the 
pattern and degree of N-methylation, highlighting the impact that small stereochemical 
differences can have on the global conformations of small cyclic peptides.
H/D exchange studies
To test the hypothesis that intramolecular hydrogen bonding exerts regiochemical control in 
the N-methylation reaction by protecting certain amide N-H groups from alkylation (Figure 
1), we performed H/D exchange studies on 1, 2, and their N-methylated derivatives, 3 and 4 
(Figures 3b and 3c). H/D exchange experiments showed that, while all of the amide protons 
in 1 exchanged within minutes or hours, the two nonmethylated amides in 3, Leu1 and Leu4, 
exchanged much more slowly (over a period of several days; Figure 3b). Likewise with 2, 
the nonmethylated precursor showed an H/D exchange profile similar to that of 1, in which 
most of the amide N-H groups exchanged with solvent over a few hours. By contrast, the 
remaining amide N-H in 4 showed negligible exchange over 24 h (Figure 3c). Thus, the free 
amide N-H groups in both 3 and 4 were either protected sterically from solvent or were 
involved in highly stable intramolecular hydrogen bonds in CDCl3. In addition, N-
methylation appeared to stabilize these hydrogen bonds relative to the nonmethylated 
precursors, since the amides that were protected from exchange in the methylated species 
were among ones that exchanged rapidly in the nonmethylated precursors.
Passive membrane permeability studies
We tested the passive membrane diffusion rates of 1 and 2, their selectively N-methylation 
products, 3 and 4, and their permethylated derivatives, 5 and 6, in a parallel artificial 
membrane permeability assay (PAMPA)22. PAMPA distinguishes passive membrane 
diffusion behavior from active transport mechanisms23, and the resulting permeability 
values correlate well with in vivo absorption rates24 for drugs that diffuse by transcellular 
mechanisms.
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For both scaffolds, the partially methylated derivatives 3 and 4 were significantly more 
permeable than their nonmethylated precursors (Figure 4a). Indeed, the PAMPA 
permeabilities of 3 and 4 were comparable to that of the orally bioavailable drug 
propranolol. Interestingly, both permethylated derivatives, 5 and 6, were significantly less 
permeable by PAMPA than their partially methylated derivatives, with permeabilitiesas as 
low as those of the nonmethylated precursors. This result suggested that each scaffold has an 
optimal number of N-methyl groups with respect to membrane permeability, and that, at 
least for some small, conformationally constrained cyclic peptides, membrane permeability 
is not simply proportional to the number of N-methyl groups in the backbone.
To further test the hypothesis that conformation is the main determinant of membrane 
permeability in 3 and 4, we synthesized43 a regioisomer of 3 to generate 7 (Figure 4b), and 
investigated its passive membrane diffusion rate by PAMPA. Although 7 differs from 3 by 
the placement of a single N-methyl group, computational studies (see below) predict that 7 
is significantly less permeable due to its inability to form internal hydrogen bonds in a low 
dielectric environment. In contrast to the compact β-turn structure of 3, the predicted 
membrane-associated conformation of 7 has an irregular geometry in which one of the three 
N-methyl groups is in the cis amide configuration and both free amide N-H groups are 
exposed to solvent (Figure 4b).
Solution NMR studies
As predicted from H/D exchange data, the NMR solution structures of 3 and 4 in CDCl3 
showed intramolecular hydrogen bonds between the nonmethylated amide N-H groups and 
backbone carbonyls (Figures 3a and S3a). For 3, the Leu1 and Leu4 residues each form two 
transannular hydrogen bonds with each other and are flanked by two β–turns. For 4, a single 
hydrogen bond between the backbone carbonyl of D-Pro5 and Leu2 generates two opposing 
nonclassical turns, resulting in a twisted geometry (Figures 3a and S3b). For both 3 and 4, 
all of the N-methyl amides are in the trans configuration, and the N-methyl groups point 
away from the ring into solution, consistent with the hypothesis proposed in Figure 1a.
Effect of side chain substitution on N-methylation
A series of cyclic peptides based on compound 1 were synthesized in which Leu1, Leu3 and 
Leu4 were replaced with various residues of differing size, functionality, and side chain 
protection (Table S5). The selectivity observed for 1 in the N-methylation reaction was also 
observed for Leu-to-X substitutions, where X = Ala, Asp, Glu, Phe, Ser, Thr, and Tyr. No 
other N-methylation products were observed for these compounds. Not surprisingly, 
compounds that bore a carbamate or amide NH in the protected side chain (e.g., Asn, Gln, or 
Lys) became tetramethylated (data not shown). We performed a full 2D NMR analysis of 
the Leu4-to-Ser substitution (1-L4S), and found that the N-methylation pattern was the same 
as that of 3, indicating that the regiochemistry was preserved (see Supplemental 
Information). For other amino acids such as histidine and methionine, the on-resin N-
methylation resulted in product mixtures of varying complexity. However, for side chains 
that were protected with appropriate groups such as esters and ethers, the N-methylation 
selectivity was preserved, indicating that the backbone was the driving force behind the N-
methylation selectivity.
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Computational studies
We used computational simulations to further examine the relationship between N-
methylation and permeability in the cyclic peptide series cyclo[Leu-Leu-Leu-Leu-Pro-Tyr]. 
In previous studies, we successfully predicted the solution structures of two cyclic peptides 
in CDCl312 using a computational method originally developed for predicting protein loop 
conformations25. For N-methyl cyclic peptides, we modified our model to take into account 
the additional steric constraints and changes in solvation energy imposed by the N-methyl 
group (Figure S1).
We then applied this method to calculate the free energy cost of desolvation (i.e., the energy 
cost of transferring from water into the membrane) for 1, 2, and the 32 possible N-methyl 
variants of each diastereomer (Figure 5a, b). Of the 32 N-methyl variants based on scaffold 
1, the most permeable variant predicted using the computational model was 3, the major 
product of the on-resin methylation chemistry. For scaffold 2, the major N-methylation 
product, 4, was the second-most permeable N-methyl variant predicted computationally, and 
the most permeable among its 4 tetramethylated regioisomers. The computations predict that 
the free energy cost of desolvation for 5 is greater than that for 3, in accord with the 
experimental results from the PAMPA studies, while 6 and 4 are predicted to have roughly 
the same desolvation energies. Upon closer inspection of the membrane-associated 
conformations predicted for the partially and fully N-methylated version of 1, the solvent 
exposure of backbone carbonyls in the permethylated compound likely accounts for its 
higher desolvation energy compared with 3. Like amide N-H groups, carbonyl oxygens also 
form favorable interactions with water that must be overcome upon membrane insertion. 
Since these carbonyls cannot participate in internal hydrogen bonds, they are consequently 
more hydrophilic than their hydrogen-bonded analogs. Our calculations suggest that the 
experimental results may be generalized: partially N-methylated cyclic peptides are more 
permeable than their permethylated analogs as long as the pattern of N-methylation favors a 
geometry in which the remaining free NH groups can either participate in internal hydrogen 
bonds or otherwise be sterically protected from solvent. We postulate that the selective on-
resin N-methylation conditions discussed above, in particular the use of a low-dielectric 
solvent (THF) in the deprotonation step, tend to favor the formation of these highly 
permeable products.
To explore this model further, we performed computational predictions on a comprehensive 
virtual library of N-methyl cyclic peptide diastereomers based on the sequence cyclo[D/L-
Leu; D/L-Leu; D/L-Leu; D/L-Leu; D/L-Pro; L-Tyr], where all possible stereoisomers (32) 
and their N-methyl variants (32 per isomer) were sampled (1024 compounds; Figure 5c). 
The results of these calculations are consistent with our experimental observations for 1 and 
2, predicting that the free energy cost of desolvation is highly dependent on both 
stereochemistry and backbone N-methylation, and that even compounds with the same 
degree of N-methylation are expected to have widely varying permeabilities.
As predicted, the passive membrane diffusion rate of 7 was significantly lower than its 
congener 3. Indeed, this N-methyl variant was less permeable (%T = 5.7 ± 0.9) than the non-
methylated parent compound 1 (%T = 9.5 ± 1.9), suggesting that patterns of N-methylation 
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that disfavor passive membrane diffusion can expose polar groups and decrease 
permeability relative to the non-methylated forms. H-D exchange studies showed that, in 
contrast to the long exchange half lives of the two free amides of 3 (each >24 h), one of the 
amide N-H groups of 7 exchanged completely within 3 min and the other amide exchanged 
with a half life of ~2 h. These results are consistent with the observed difference in 
membrane permeability between 3 and 7, and suggest that H-D exchange rates can provide a 
sensitive means of predicting relative membrane permeability in congeneric cyclic peptides.
Permeability of expanded set of N-methylation products
While screening reaction conditions for compound 1, we found that the choice of solvent for 
both the base treatment and the CH3I addition impacted the extent of N-methylation along 
with the total number and identity of the products observed. For example, the use of CH2Cl2 
for both reactions tended to yield products with fewer N-methyl groups, while the use of 
THF in both steps caused greater N-methyl incorporation but less selectivity than when 
DMSO was used for the CH3I addition. We therefore selected a set of diastereomers 
(Scaffolds 12, 19, 21, and 23, Figure 2a) that showed varying selectivity in the on-resin N-
methylation reaction, and then further increased the number of N-methyl products observed 
for each scaffold by varying the reaction conditions. By attenuating the selectivity of the N-
methylation chemistry and using different stereoisomeric scaffolds, we were able to observe 
48 distinct N-methyl products ranging from non-methylated to permethylated peptides. 
PAMPA permeability measurements were made on the 4 N-methyl product mixtures from 
each scaffold plus the non-methylated precursors. Independent control studies were 
performed on a set of pure compounds to verify that %T values from the product mixtures 
were the same as the %T values determined for the pure compounds. The results, 
summarized in Figure 5d, show that even among compounds with the same number of N-
methyl groups (i.e., regio- and stereoisomers), permeabilities vary greatly. The results also 
corroborate the computational predictions in that the most permeable trimethylated 
compounds were more permeable than any of the permethylated species. All four scaffolds 
produced at least one N-methyl product with a PAMPA permeability (%T > 25%) 
comparable to that of many orally bioavailable drugs26. Thus, even among scaffolds that 
showed poor selectivity in the on-resin N-methylation chemistry (scaffolds 12, 21, and 23), 
N-methylated derivatives exist that are highly permeable, indicating that while selectivity in 
the on-resin N-methylation reaction is associated with excellent permeability, it is not a 
precondition for it. These compounds are accessible, in principle, using the type of site-
specific N-methylation chemistry used to synthesize 7.
In vitro and in vivo pharmacokinetics studies
The permeabilities of peptides 1, 2, and their N-methylated analogs were also examined in a 
cell-based RRCK permeability assay.1 This assay uses a stable population of MDCK cells 
that were selected by flow cytometry to have little or no functional Pgp, and therefore 
provide a good measure of passive, transcellular permeability with minimal interference 
from active transport mechanisms associated with Pgp expression (unpublished results). 
Compounds 1 and 2 showed relatively low cell permeability in RRCK cells, while their 
partially methylated derivatives, 3 and 4, were significantly (3 to 10-fold) more permeable 
than the corresponding non-methylated precursors (Table 1). As in the PAMPA results, 
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compound 5 appears to be less permeable than the partially methylated species in the RRCK 
assay. However, 6 was the most permeable among the compound 2 series in the RRCK 
assay, a result that contrasted with the PAMPA data showing 6 to be less permeable than 
partially methylated 4. Despite this discrepancy between the PAMPA and cell-based 
permeability data for 2, the computational data on these compounds predicted 4 and 6 to 
have essentially the same permeability. All of the N-methylated compounds in this study 
had better cell permeability in the RRCK assay than the orally bioavailable drug CSA.
In addition to the cell permeability studies, the compound series based on 1 and 2 was tested 
in vitro for stability in human plasma and in liver microsomes from rats and humans. These 
assays provide a general measure of the stability of compounds toward degradation by 
proteolytic and CYP enzymes, respectively. All of the cyclic peptides studied were stable in 
human plasma (t1/2 > 360 min), consistent with the stabilizing effect of cyclization (and 
possibly the presence of D-residues) toward proteolytic degradation. In human liver 
microsomal stability assessments, compounds 1, 2, and their methylated variants were less 
stable than CSA, as reflected in the higher CLint values (Table 1). Further, the partially 
methylated compound 3 had greater microsomal stability than either its non- or 
permethylated derivative, while partially methylated 4 was significantly less stable than 
either 2 or 6. Overall, for both series, stability was greater in rat than human liver 
microsomes, suggestive of species-specific differences in metabolism. Surprisingly, 
compounds 1 and 2 had very different microsomal clearance rates even though they have the 
same sequence and molecular weight, differing only by the relative configurations at two 
stereocenters. Thus, conformation not only plays a large role in determining passive cell 
permeability in cyclic peptides, but it also has a significant impact on their stability toward 
oxidative metabolism.
Effect of side chain substitutions
Most N-methylated cyclic peptide natural products contain a preponderance of aliphatic 
residues, although many also contain neutral, polar side chains such as Thr and Ser. We 
investigated the effect of polar side chain substitutions on the pharmacokinetic parameters of 
compound 3 by making Leu-to-Ser substitutions at positions 1, 3 and 4, and testing the 
resulting compounds in the PAMPA and cell-based permeability assays along with the in 
vitro serum and microsomal stability assays (Table 2). A single Leu-to-Ser substitution in 3 
caused the RRCK cell permeability to drop by ~65% for Leu1 and Leu3, and by 85% for 
Leu4. The Leu1-to-Ser and the Leu3-to-Ser substitutions improved HLM stability slightly 
relative to the parent compound, while the Leu4-to-Ser substitution significantly decreased 
HLM stability. The same trend was observed in the RLM stability measurements. As 
expected, these hydrophobic-to-polar group substitutions decreased cell permeability, 
although from the standpoint of potential oral bioavailability, this decrease is partially offset 
by a concomitant increase in microsomal stability. There is also a relatively strong positional 
effect on both permeability and microsomal stability, in that the Leu4-to-Ser replacement 
had a greater impact on both permeability and stability than the Leu1 and Leu3 substitutions.
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In vivo pharmacokinetics studies
The in vivo pharmacokinetics of 3 in male Wistar-Han rats are summarized in Table 3. The 
intravenous pharmacokinetics of 3 in rats are characterized by a low CLp (~ 4.5 mL/min/kg) 
and a moderate Vdss (1.1 L/kg), leading to a terminal elimination (t1/2) of 2.8 h. The absolute 
oral bioavailability (F) of 3 was determined to be ~ 28%, a value remarkably similar to that 
reported for CSA27–29. CSA and 3 also showed very similar AUC and Cmax values 
following the same oral dose of 10 mg/kg.
Discussion
We have shown that cyclic peptides can be selectively N-methylated on the solid phase 
under conditions that for linear peptides are known to induce complete N-methylation19, 20. 
The fact that the observed selectivity was highly dependent on scaffold geometry points 
toward conformation as the key selectivity determinant. The H/D exchange results suggest 
that backbone N-methylation rigidifies the conformation of the peptide, since the free amide 
N-H groups exchanged much more slowly in 3 and 4 than in their nonmethylated precursors. 
This observation is consistent with the prediction that certain patterns of N-methylation 
stabilize hydrogen-bonded conformations by decreasing flexibility in the peptide backbone.
The H/D exchange results for the non-methylated peptides 1 and 2 suggested that they are in 
conformational flux among multiply hydrogen-bonded states on a time scale of seconds to 
minutes. However, the high degree of selectivity observed in the on-resin N-methylation for 
these compounds would seem to require restricted conformational freedom on this time 
scale. While this discrepancy may be due to solvent differences between the H/D exchange 
(chloroform) and N-methylation reactions (THF), we postulate that the amide deprotonation 
events are sequential and cooperative, such that deprotonation of the most exposed N-H 
limits the flexibility of the molecule and renders one or more of the remaining exposed 
amides more acidic. In other words, initial deprotonation of the most exposed N-H could 
shift the conformational equilibrium in the precursor toward the hydrogen-bonded 
conformation found in the product. This hypothesis is supported by a report showing that, 
while hydrogen bonding protects the involved amide N-H from H/D exchange, it increases 
the exchange rate of the amide whose carbonyl is participating as the H-bond acceptor30.
The permethylated versions of both 1 and 2 were significantly less permeable than their 
partially N-methylated counterparts, 3 and 4, in the PAMPA permeability measurements. 
For compound 1, the same trend was observed in the RRCK permeability assay, in which 3 
was more permeable than either 1 or 5. This was likely due to the greater solvent exposure 
of hydrophilic carbonyl groups in the permethylated derivatives, which were sequestered in 
hydrogen bonds in the partially methylated compounds. Since none of the amide carbonyls 
in permethylated cyclic peptides can participate in intramolecular hydrogen bonding, we 
predict that these compounds will be less permeable, in general, than those partially 
methylated derivatives that can achieve optimal internal hydrogen bonding. Because the 
synthetic strategy outlined here afforded preferential N-methylation of exposed NH groups 
over those involved in internal hydrogen bonds, we postulate that these conditions can lead 
to methylated cyclic peptides with optimal or nearly optimal passive membrane 
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permeability. In many cases, the most optimal conformation in terms of permeability may 
not be the predominant conformation selected by the N-methylation chemistry. However, 
given that hydrogen bonding is favorable to both permeability and selectivity, it is likely that 
the products of the on-resin N-methylation reaction will be among the most permeable of the 
many possible N-methyl variants.
For the compound 2 series, the cell-based permeability results are in partial conflict with the 
PAMPA data. In cells, 6 was more permeable than either 4 or the parent compound 2, while 
in PAMPA the 2 series followed the same trend as 1, with the partially methylated species 
showing the greater permeability. The discrepancy between the relative PAMPA and cell-
based permeability values between 6 and 4 may lie in the differences between these two 
assays. The former is comprised of a relatively thick alkane layer impregnated with 
phospholipids, while the latter is a bona fide cell membrane. Where PAMPA and RRCK 
permeabilities disagree, the cell-based assay should be considered the more biologically 
relevant result with respect to passive membrane diffusion and is likely to be the better 
predictor of oral bioavailability.
We found that replacing a single Leu residue with Ser caused a significant loss in 
permeability. The magnitude of that loss, however, was dependent on the position of the 
substitution, indicating that the effect of polar side chains on permeability is dependent not 
only on the intrinsic polarity of the particular functional group, but also on its location along 
the backbone. This effect could result from a position-dependent interaction between the 
side chain hydroxyl and the backbone in a way that perturbs the backbone conformation, 
although preliminary calculations suggest that the beta structure of 3 is robust to side chain 
substitutions (data not shown).
While the cell-based permeabilities of the Leu-to-Ser substitutions were significantly lower 
than those of the all-Leu analogs, their PAMPA permeabilities were so low that they were 
undetectable. The threshold of detection for this assay put an upper limit on these values at 
0.08% T, which, while consistent with the RRCK results in relative terms, predicted a more 
profound loss in permeability for these compounds than the cell-based results indicate. This 
difference in magnitude between the two results may also reflect the differences in the 
physical properties between the relatively thick hydrophobic spacer in the PAMPA vs. the 
true bilayer of a cell.
It is worth noting that the scaffold and N-methylation pattern found in 3 is similar to that 
identified by Biron, et al.4 in their N-methyl scan of the Veber-Hirschmann somatostatin 
analog cyclo[Pro–Phe–D-Trp–Lys–Thr Phe]31. In their study, an extensive N-methyl scan 
led to 30 analogs, of which a subset cyclized efficiently to yield the desired N-methyl cyclic 
peptide. Of the 7 N-methyl variants whose affinity toward the somatostatin receptor was 
similar to that of the wild type sequence, only the parent sequence and a single trimethyl 
variant, cyclo[Pro–Phe–DTrp(NMe)–Lys(NMe)–Thr–Phe(NMe)], showed significant in 
vivo uptake. Although the relative placement of the conformation-determining D-Trp and 
Pro residues in this trimethylated version of the Veber-Hirschmann peptide differ from that 
of 3, both peptides adopt similar backbone structures in which the D-residue and the Pro 
form two opposing β-turns with the nonmethylated amides participating in transannular 
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hydrogen bonds. This conformation, in which the positioning of the two D-residues 
templates the formation of two opposing β-turns, is likely the key determinant of both the N-
methylation regiochemistry in compound 1 and the membrane permeability of its trimethyl 
adduct. The reported oral bioavailability of this peptide is 9%6, a value comparable to that of 
28% for 3.
While the strategy reported here may help identify novel membrane permeable scaffolds, its 
ability to confer bioavailability to peptide sequences with known bioactivity is limited. In 
many cases, N-methylation is likely to diminish biological activity, either by directly 
blocking interactions of the backbone with its receptor or by driving the peptide into an 
inactive conformation. However, varying both stereochemistry and N-methyl placement for 
a given sequence may yield novel scaffolds that retain biological activity while showing 
improved permeability.
The observation that 3 is significantly more permeable than 5 may provide insight into the 
relative scarcity of permethylated cyclic peptide natural products. A survey of the online 
Dictionary of Natural Products revealed that, among ~353 cyclic peptide and depsipeptide 
natural products whose chemical structures have been deposited, 146 have partially N-
methylated backbones whereas only two are completely N-methylated. While the 
biosynthesis of N-methyl cyclic peptides by non-ribosomal peptide synthetases (NRPS) may 
disfavor permethylated species simply due to steric strain in the cyclization step, it is 
tempting to speculate that the pattern of N-methylation observed in cyclic peptides of natural 
origin may be driven, at least in part, by selective pressure to maximize membrane 
permeability. Such selective pressure may exist for peptide natural products created by 
bacteria to interact with eukaryotic host organisms.
Large cyclic peptide natural products, and macrocycles in general, may occupy “islands of 
bioactivity”* in chemical space that become increasingly sparse with increasing molecular 
mass. We postulate that many of these islands are populated with bioactive natural products 
whose properties have been optimized by the action of natural selection, although it is likely 
that many other islands remain undiscovered. A combination of the synthetic and 
computational approaches described here may open these regions of chemical space up to 
the discovery of new macrocyclic scaffolds with drug-like oral bioavailability similar to 3, a 
755-molecular weight compound that nonetheless achieves acceptable oral bioavailability.
Methods
Peptide synthesis and N-methylation
Cyclic peptides were synthesized starting with the allyl ester of Fmoc-protected tyrosine, 
Fmoc-Tyr(OH)-OAll, linked as a silyl ether via the phenolic OH to an all-alkyl silyl-tethered 
polystyrene resin according to published procedures12. For large-scale syntheses (>0.5 
mmol, or 1 g resin), peptides were synthesized and cyclized using an automated peptide 
synthesizer (Prelude, Protein Technologies, Inc.). For the 32-diastereomer library, a 96-well 
deep-well filter plate was used (Arcticwhite, LLC) with a manifold for solvent removal and 
*This term was coined by David Hepworth and Spiros Liras of Pfizer, Inc.
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an 8-channel trigger dispenser to dispense wash solvents and the deprotection solution. In 
general, couplings were performed using 4 eq Fmoc-protected amino acid, 3.8 eq HBTU, 
and 6 eq DIPEA in DMF (0.1 M in amino acid) for 1.5–3 h. Fmoc deprotections were 
carried out with 2% DBU/DMF for 15 min. After each coupling and deprotection step, the 
resin was washed with DMF (3x), DCM (3x), and DMF (3x). After the addition of the final 
residue, deallylation and final Fmoc removal were performed simultaneously with a solution 
of 1 eq Pd(Ph3P)4 in THF containing 10% v/v piperidine for 3 h. A chelating wash was 
performed to remove traces of Pd using 5% v/v sodium diethyldithiocarbamate/5% v/v 
DIPEA in DMF, followed by the normal DMF/DCM/DMF resin wash sequence. Cyclization 
was performed with 3 eq HATU, 3.2 eq HOAT, and 5 eq DIPEA in DMF for 3 h, followed 
by resin washing with two final DCM washes to remove residual DMF. Peptides were either 
cleaved following cyclization, or N-methylated (see below) and then cleaved by treating the 
resin (100 mg) with 5% HF/pyridine in THF (5 mL) for 1 h. The filtrate was collected into a 
polypropylene tube, and the reaction was quenched with 500 μL ethoxytrimethyl silane. 
After evaporation, the peptide was taken up into ACN/H2O (3:1) and purified by reverse-
phase preparative HPLC. For peptides that contained side chain protecting groups, a final 
deprotection was performed using a solution of 5% v/v trimethylsilane in TFA for 1 h. The 
solution was evaporated, and the peptide was taken up into a 1:1 solution of water/ACN and 
either purified immediately or lyophilized and stored at −20°C.
On-resin N-methylation
The following procedure was developed for on-resin N-methylation using 1 g of resin at a 
loading of ~0.13 mmol/g of peptide: A solution of LiOtBu (25 mL; 1.5 M) in dry THF was 
filtered through a 0.2 μ syringe filter and then added to the resin. After 30 min the base 
solution was drained and, without rinsing, a 10% (v/v) solution of methyl iodide in DMSO 
(25 mL) was added and the resin was agitated for 30 min. The resin was rinsed with water 
(1x), methanol (3x), DCM (3x), DMF (3x), and DCM (3x), and then dried under vacuum. 
The cyclic peptide was cleaved (see procedure above), and the crude peptide was purified by 
reversed-phase HPLC on a C-18 10 μ 250×20 mm column using a typical gradient of 40% 
H2O/ACN (with 0.1% TFA) to 100% ACN (0.1% TFA) over 1 h. The resulting peptide was 
lyophilized to yield 3 (26 mg) as a white solid (25% based on resin loading). LRMS (ESI): 
Calculated for C41H66N6O7 (MH+): 755.5; found: 755.6. The same procedure was followed 
for the N-methylation of all other N-methyl peptides. For 4, after purification and 
lyophilization, 15 mg of a white solid was obtained (15% based on resin loading). LRMS 
(ESI): Calculated for C42H66N6O7 (MH+): 769.0; found: 769.2.
On-resin N-methylation to generate permethylated compounds 5 and 6
Cyclic peptides were synthesized as above, and, without cleaving, the resin (0.1 g, 0.4 
mmol/g) was dried in vacuo with phosphorus pentoxide for 24 h. A mixture of dry THF (3 
mL) and dry DMSO (2.4 mL) was then added to the resin and agitated with dry N2. LiOtBu 
(32 mg, 10 eq) was added, and the mixture was agitated with N2 for 20 min. 600 μL of CH3I 
was added via syringe, and the reaction was agitated with N2 for 20 min. The resin was 
filtered and washed multiple times with THF and DCM. Cleavage of peptides from the resin 
and purification by preparative HPLC yielded 5 (5 mg) or 6 (3 mg) as white solids. LRMS 
(ESI) for both peptides: Calculated for C43H71N6O7 (MH+): 783.5; found: 783.6.
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H/D exchange studies
All NMR spectra for the H/D exchange studies were recorded at 297 K on a 600 MHz 
Varian Inova spectrometer equipped with a 5 mm inverse detection probe. Spectra were 
referenced to residual solvent proton signals (1H 7.26 for CDCl3). Peptides were dissolved 
in 665 μL CDCl3 at 6 mg/mL. Prior to initiating the H/D exchange reaction, a spectrum was 
recorded (t = 0). The NMR tube was removed from the spectrometer, and a solution of 35 
μL CD3OD containing 10% CD3CO2D was added by syringe to a final concentration of 5% 
v/v CD3OD and 0.5% CD3CO2D. Upon addition of the deuterated solvents and quick 
agitation, a stopwatch was started and the NMR tube was returned to the spectrometer. 
Spectra were recorded using 8 FID transients for each time point at increasing intervals over 
a period of 16 h. H/D exchange rates were measured by integrating each exchangeable 
amide resonance separately and recording the ratio of its peak area vs. the peak area for a 
downfield non-exchangeable C(α)H resonance.
Additional methods
The PAMPA assay, in vitro and in vivo pharmacokinetics studies, NMR spectroscopy and 
structure determination, and computational methods are described in detail in the 
Supplementary Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
a) Schematic representation of the conformational hypothesis of membrane permeability 
applied to N-methyl cyclic peptides. b) General strategy for on-resin N-methylation of cyclic 
peptides to generate scaffolds with improved permeability.
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Figure 2. 
a) Diastereomer library screened for N-methylation selectivity. Arrows represent sequences 
that showed >95% selectivity for a single partially methylated species; all other sequences 
showed no reaction, permethylation, or mixtures of N-methyl products of varying 
complexity. Scaffolds 18 and 19 correspond to compounds 2 and 1, respectively. b) 
Consensus sequences for trimethyl- and tetramethyl-selective compounds.
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Figure 3. 
a) Reaction sequence in the on-resin N-methylation of 1 and 2, and the resulting pattern of 
alkylation to generate 3 and 4, respectively. H/D exchange studies on 1 and 3 (b) along with 
2 and 4 (c). Amide N-H resonances were monitored as a function of time after addition of 
5% MeOH-d4/0.5% HOAc-d4.
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Figure 4. 
(a) Passive membrane permeabilities of compounds based on diastereomer 1 (white bars), 
diastereomer 2 (hashed bars), and the orally bioavailable positive control propranolol (grey 
bar) determined using the parallel artificial membrane permeability assay (PAMPA). %T 
calculated as the percentage of analyte entering the acceptor compartment after 16 h, where 
100% T corresponds to equilibrium between donor and acceptor compartments. (b) 
Schematic structure of 7, an isomer of 3 with a different pattern of N-methylation, and a 
stereoview of its predicted membrane-associated conformation. (c) Table showing H-D 
exchange data for compounds 3 and 7.
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Figure 5. 
Predicted free energies of desolvation of all N-methyl variants for scaffolds 1 (a) and 2 (b). 
Compounds 3 and 4 are indicated with red circles. Compound 7 is indicated with a blue 
circle. c) Predicted free energies of desolvation of all N-methyl variants for all diastereomers 
based on the sequence cyclo[D/L-Leu; D/L-Leu; D/L-Leu; D/L-Leu; D/L-Pro-LTyr]. d) 
Boxplot showing the PAMPA permeabilities (%T) as a function of the number of N-methyl 
groups for starting materials (0 N-methyls) and products (1–5 N-methyls) derived from the 
on-resin N-methylation of scaffolds 12, 19, 21, and 23 (Figure 2a) under three different 
solvent conditions: 1) LiOtBu (THF)/CH3I (THF), 2) LiOtBu (DCM)/CH3I (DCM), 3) 
LiOtBu (THF)/CH3I (DMSO).
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Table 1
In vitro cell permeability, microsomal stability, and serum stability data for selected cyclic peptides.
compound RRCK pH 7.4(× 106cm/s) HLM Clint (μg/min/mg) RLM Clint (μg/min/mg) Human plasma stab (t1/2, min)
CSA 1.1 46.8 14.1 > 360
1 1.8 225 243 > 360
3 4.9 110 30.4 > 360
5 3.5 >320 317 >360
2 0.5 109 47.1 >360
4 4.1 >320 >491 >360
6 6.1 191 62.6 >360
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